Different gene mutations were identified in patients with Ewing sarcoma: TP53 mutations occurred in 5% - 20% of cases, amplifications of MDM2 occurred in up to 10% of the cases, deletions of the CDKN2A in about 15% of the cases [15]. This evidence concerns the gene CDKN2A and Ewing sarcoma.